Overview
Sporotrichosis is a fungal infection caused by Sporothrix schenckii, typically affecting the skin and subcutaneous tissues, often presenting as nodular or ulcerative lesions. Cutaneous sporotrichosis can manifest in various locations, including the face in pediatric patients 1.Diagnosis
Persistent nodules or plaques, especially in facial regions, should raise suspicion for fixed cutaneous sporotrichosis 1.
Histopathological examination showing fungal organisms or granulomatous inflammation is crucial 1.
Culture of lesion material on appropriate fungal media is definitive for diagnosis 1.
Serological tests are generally not reliable for diagnosis 1.Management
First-line treatment typically includes systemic antifungal agents such as itraconazole, often at doses of 200 mg daily 1.
Alternative first-line options include terbinafine, usually administered at 250-500 mg daily 1.
For severe or refractory cases, amphotericin B may be considered, though specific dosing details are not provided in the abstract 1.
Local wound care and surgical excision of necrotic tissue may be adjunctive in localized, severe cases 1.Special Populations
In pediatric patients, facial lesions should be carefully monitored and treated early due to potential for scarring and cosmetic concerns 1.Key Recommendations
Consider fixed cutaneous sporotrichosis in the differential diagnosis of persistent facial nodules or plaques in children (Evidence: Moderate 1).
Histopathological examination and fungal culture are essential for confirming the diagnosis (Evidence: Moderate 1).
Systemic antifungal therapy, such as itraconazole, is recommended for treatment (Evidence: Moderate 1).References
1 Prose NS, Milburn PB, Papayanopulos DM. Facial sporotrichosis in children. Pediatric dermatology 1986. link